Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,492 signal articles · 183 in last 24h · 116,679 total before filter · latest 23m ago
183last 24h
1710last 7d
279● bullish (7d)
150● bearish (7d)
205publishers
AllMacro321Earnings765M&A102Regulatory25Product16Analyst24
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Meta And Alphabet Offer Incredible Value And No One Cares
24/7 Wall St.3d agoneutral
Meta And Alphabet Offer Incredible Value And No One Cares

Meta's ad engine is humming and Alphabet's cloud is accelerating, yet both stocks trade at multiples that look almost suspiciously cheap for hyperscalers of this caliber. Something is keeping investors away, and figuring out what reveals a lot about where the real opportunity sits.

Are ‘boring’ sectors back?
Moneyweek3d agoneutral
Are ‘boring’ sectors back?

Volatility is desirable for many investors, but there’s still a lot to be said for picking up well-valued companies alongside growth stocks.

Robinhood Ventures Fund II opens startup investing to retail
Proactive3d agoneutral
Robinhood Ventures Fund II opens startup investing to retail

Robinhood Markets Inc (NASDAQ:HOOD) has raised $225.5 million for a new publicly traded fund that gives everyday investors exposure to private startups. The trading and investment company priced the initial public offering of Robinhood Ventures Fund II at $25 per share on the New York Stock...

Latest News In AI Chips - Cerebras Expands Amidst Rising Demand For AI Innovation
Simply Wall St.3d agoneutral
Latest News In AI Chips - Cerebras Expands Amidst Rising Demand For AI Innovation

Cerebras Systems recently reported significant growth in its AI chip and cloud businesses, with its cloud revenue nearly quadrupling year-over-year in the second quarter of 2026. This growth highlights the increasing demand for fast AI inference, a pivotal development in the AI chip industry. In response to this demand, Cerebras is expanding its data center and manufacturing capacities significantly, aiming to scale its operations further. Additionally, strategic partnerships with industry...

Wall Street set for steady start after S&P 500's record close
Proactive3d agoneutral
Wall Street set for steady start after S&P 500's record close

Wall Street looks set for a calm end to the week, with US stock futures drifting close to flat on Friday. That comes after the S&P 500 powered to a fresh record high on Thursday, buoyed by softer-than-expected inflation figures and receding worries about further Federal Reserve interest...

Why I’ve Begun Accumulating ON Semiconductor
24/7 Wall St.3d agoneutral
Why I’ve Begun Accumulating ON Semiconductor

The market still prices ON Semiconductor like a struggling cyclical, but the power infrastructure feeding AI data centers, EV platforms, and grid-scale storage tells a completely different story about where this company is headed.

SEC Delays Vote on Exemptions for Crypto Fundraising
Cryptonews3d agoneutral
SEC Delays Vote on Exemptions for Crypto Fundraising

In SEC crypto news today, the Securities and Exchange Commission canceled its August 14 open meeting, which had been scheduled to consider whether to propose new crypto-related rules. An SEC spokesperson said the meeting would be moved due to an unforeseen scheduling issue, and no replacement date was announced. What ...

Enovix (ENVX) Could Be 66% Below Fair Value As Revenue And Guidance Improve
Simply Wall St.3d agoneutral
Enovix (ENVX) Could Be 66% Below Fair Value As Revenue And Guidance Improve

Enovix (ENVX) just reported second quarter revenue of US$9.02 million, alongside guidance for third quarter revenue of US$9.0 million to US$10.0 million, highlighting continued traction in Smart Eyewear and drone or defense orders. See our latest analysis for Enovix. Despite the upbeat Q2 revenue and guidance, Enovix’s share price has been under pressure, with the latest close at US$4.43 and the year to date share price return down 43.9%, while the 1 year total shareholder return has fallen...

Amgen (AMGN) Opens New Science And Innovation Center In Hyderabad
Simply Wall St.3d agoneutral
Amgen (AMGN) Opens New Science And Innovation Center In Hyderabad

Amgen (NasdaqGS:AMGN) announced the opening of a new Science and Innovation Center in Genome Valley, Hyderabad, expanding its global research and development presence. The Hyderabad center is designed to integrate scientific capabilities with data and digital tools to support discovery and development of new medicines. This expansion adds another research hub to Amgen's global footprint and increases its geographic diversification in Asia. Amgen is not the only healthcare stock investing in...